Global Alkaloid Based Drugs Market, By Type (True Alkaloids, Protoalkaloids, Pseudoalkaloids), Chemical Structure Type (Typical Alkaloids, Atypical Alkaloids), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Application (Analgesic, Antimalarial, Antibacterial, Anticancer, Cholinomimetic, Antiasthma, Antiarrhythmic, Vasodilatory, Antihyperglycemic), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2030.
Alkaloid Based Drugs Market Analysis and Size
The rise in the prevalence of diseases such as cancer, malaria, asthma, lifestyle disorders, and growing healthcare expenditure are the major factors influencing the market growth rate. Furthermore, growing demand for novel therapies and treatments, advancement of medical technology, and growing government funding are the factors that will expand the global alkaloid based drugs market. Also, changing lifestyle and increases in disposable income are the drivers that will cushion the market growth rate.
Data Bridge Market Research analyses that the global alkaloid based drugs market which was USD 2.78 Billion in 2022, would rocket up to USD 5,65 Billion by 2030, and is expected to undergo a CAGR of 6.9% during the forecast period. This indicates that the market value. “Protalkaloids” is expected to dominate the type segment of the global alkaloid based drugs market owing to the increasing prevalence of diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Alkaloid Based Drugs Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Type (True Alkaloids, Protoalkaloids, Pseudoalkaloids), Chemical Structure Type (Typical Alkaloids, Atypical Alkaloids), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Application (Analgesic, Antimalarial, Antibacterial, Anticancer, Cholinomimetic, Antiasthma, Antiarrhythmic, Vasodilatory, Antihyperglycemic), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) |
|
Countries Covered |
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa |
|
Market Players Covered |
Alchem International Pvt. Ltd.(India), Van Wankum Ingredients(Netherlands), Vital Laboratories Pvt Ltd.(India), Chempro Pharma Private Limited(India), Pfizer Inc.(U.S.), GlaxoSmithKline plc(U.K.), Sun Pharmaceutical Industries Ltd.(India), Eli Lilly and Company(U.S.), Novartis AG(Switzerland), Teva Pharmaceutical Industries Ltd.(Israel), Abbott(U.S.), Merck Sharp & Dohme Corp.(U.S.), Allergan(Ireland), Mylan N.V.(U.K.), VERVE HEALTH CARE LTD. (India), Mallinckrodt(U.K.), DAIICHI SANKYO COMPANY, LIMITED. (Japan), Hikma Pharmaceuticals PLC(U.K.) Indena S.p.A(Italy), Phytochemindo Reksa (PT. PRI) (Indonesia). |
|
Market Opportunities |
|
Market Definition
Alkaloid is defined as a member of a large group of chemicals that are derived from plants. There are referred to the naturally occurring nitrogenous groups that contain organic bases. Many alkaloids have strong pharmacological effects. Alkaloids are often classified according to their common molecular precursors, based on the biological pathway used to construct the molecule. The common alkaloids are nicotine, cocaine, strychnine, morphine, caffeine, pilocarpine, methamphetamine, atropine, ephedrine, mescaline, and tryptamine.
Global Alkaloid Based Drugs Market Dynamics
Drivers
- Increasing Prevalence of Diseases
Alkaloid-based drugs have shown therapeutic potential in treating various diseases such as cancer, cardiovascular disorders, central nervous system disorders, and infectious disease. The rising prevalence of these conditions drives the demand for alkaloid-based drugs.
- Growing Aging Population
With an aging population worldwide, there is an increased need for effective medications to address age-related health issues. Alkaloid-based drugs have demonstrated efficacy in managing age-related conditions, driving their demand.
- Advancements in Drug Discovery
Continuous advancements in drug discovery techniques and technologies contribute to the identification and development of new alkaloid-based drugs. These innovations expand the market and offer novel treatment options.
- Increasing Research and Development Activities
Pharmaceutical companies, academic institutions, and research organizations are actively investing in R&D activities related to alkaloid-based drugs. This focus on research helps in discovering new therapeutic applications and improving existing drugs.
Opportunities
- Untapped Therapeutic Potential
Alkaloids are a diverse group of compounds found in nature, offering a vast untapped potential for therapeutic applications. Exploring new alkaloid sources and researching their pharmacological properties present opportunities for the development of innovative drugs.
- Personalized Medicine
Alkaloid-based drugs can be tailored to individual patients based on their genetic profiles and disease characteristics. The emerging field of personalized medicine opens up opportunities for the development of targeted alkaloid therapies.
Restraints
- Side Effects and Toxicity
Alkaloid-based drugs may exhibit side effects and toxicities, which can limit their usage and acceptance. Adverse reactions or safety concerns associated with these drugs pose challenges to their widespread adoption
- Stringent Regulatory Requirements
The regulatory landscape for drug approval and commercialization is rigorous. Meeting the stringent regulatory requirements, such as clinical trials and safety assessments, can be time-consuming and costly, acting as a restraint for market growth.
Challenges
- Generic Competition
Patent expirations and the subsequent entry of generic alternatives can pose a threat to the market share of branded alkaloid-based drugs. Generic competition often leads to price erosion and reduced revenue for original drug manufacturers.
- Alternative Treatment Modalities
Other treatment options, such as synthetic drugs, biologics, and emerging therapies like gene therapy or immunotherapy, may pose competition to alkaloid-based drugs. The availability of alternative treatment modalities can influence market demand.
This global alkaloid based drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global alkaloid based drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In December 2021, Pfizer Inc., a leading American multinational pharmaceutical and biotechnology corporation announced its acquisition of Arena Pharmaceuticals, Inc., an American biopharmaceutical company. With this acquisition, the companies aimed to develop innovative potential therapies for the treatment of several immune-inflammatory diseases including cancer, cardiovascular diseases, skin diseases, and many more.
Global Alkaloid Based Drugs Market Scope
The global alkaloid based drugs market is segmented on the basis of power source, product, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- True Alkaloids
- Protoalkaloids
- Pseudoalkaloids
Chemical Structure type
- Typical Alkaloids
- Atypical Alkaloids
Dosage
- Tablet
- Injection
- Others
Route of Administration
- Oral
- Intravenous
- Others
Application
- Analgesic
- Antimalarial
- Antibacterial
- Anticancer
- Cholinomimetic
- Antiasthma
- Antiarrhythmic
- Vasodilatory
- Antihyperglycemic
End User
- Clinic
- Hospital
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Alkaloid Based Drugs Market Regional Analysis/Insights
The global alkaloid based drugs market is analysed and market size insights and trends are provided by country, power source, product, and application as referenced above.
The countries covered in the alkaloid based drugs market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America is expected to dominate the alkaloid based drugs market due to the presence of major key players, due to growing investment for R&D activities, and the well-developed healthcare sector in this region
Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in healthcare infrastructure, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global alkaloid based drugs market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kind of products for the global alkaloid based drugs market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global alkaloid based drugs market. The data is available for the historic period 2015-2020.
Competitive Landscape and Alkaloid Based Drugs Market Share Analysis
The global alkaloid based drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global alkaloid based drugs market.
Some of the major players operating in the global alkaloid based drugs market are:
- Alchem International Pvt. Ltd. (India)
- Van Wankum Ingredients (Netherlands)
- Vital Laboratories Pvt Ltd. (India)
- Chempro Pharma Private Limited (India)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Sun Pharmaceutical Industries Ltd. (India)
- Eli Lilly and Company (U.S.)
- Novartis AG(Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Abbott (U.S.)
- Merck Sharp & Dohme Corp. (U.S.)
- Allergan (Ireland)
- Mylan N.V.(U.K.)
- VERVE HEALTH CARE LTD. (India)
- Mallinckrodt (U.K.)
- DAIICHI SANKYO COMPANY, LIMITED. (Japan)
- Hikma Pharmaceuticals PLC(U.K.)
- Indena S.p.A(Italy)
- Phytochemindo Reksa (PT. PRI) (Indonesia)
SKU-
